Skip to search formSkip to main contentSkip to account menu

Methylphenidate

Known as: Methylphenidate [Chemical/Ingredient], MPH, Methylphenidatum 
A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
The authors review the available empirical evidence from population-based studies of the association between perceptions of… 
Review
2007
Review
2007
Background and Purpose— The modified Rankin scale (mRS), a clinician-reported measure of global disability, is widely applied for… 
Review
2005
Review
2005
Review
2003
Review
2003
Objectives. Racial/ethnic disparities in health in the U.S. have been well described. The field of “cultural competence” has… 
Highly Cited
2003
Highly Cited
2003
Purpose. To determine the relationship between urban sprawl, health, and health-related behaviors. Design. Cross-sectional… 
Highly Cited
2001
Highly Cited
2001
Methylphenidate (Ritalin) is the most commonly prescribed psychoactive drug in children for the treatment of attention deficit… 
Highly Cited
2000
Highly Cited
2000
The indirect catecholamine agonist methylphenidate (Ritalin) is the drug treatment of choice in attention deficit/hyperactivity… 
Highly Cited
1998
Highly Cited
1998
OBJECTIVE The therapeutic effects of methylphenidate in the treatment of attention deficit disorder have been attributed to its… 
Highly Cited
1998
Highly Cited
1998
Functional MRI revealed differences between children with Attention Deficit Hyperactivity Disorder (ADHD) and healthy controls in… 
Highly Cited
1971
Highly Cited
1971
Five centrally acting sympathomimetic amines, d‐amphetamine, d‐methamphetamine, ephedrine, phenmetrazine, and methylphenidate…